Feature Channels: Respiratory Diseases and Disorders

Filters close
Newswise: Respiratory Societies Help Bring the World Together for Bronchiectasis
Released: 1-Jul-2024 9:05 AM EDT
Respiratory Societies Help Bring the World Together for Bronchiectasis
American Thoracic Society (ATS)

In support of the third annual World Bronchiectasis Day, July 1, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is joining the COPD Foundation and several global organizations to raise awareness, share knowledge, and discuss ways to reduce the burden of bronchiectasis for patients and their families worldwide.

Not for public release

This news release is embargoed until 28-Jun-2024 12:15 AM EDT Released to reporters: 28-Jun-2024 12:15 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 28-Jun-2024 12:15 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Study supports precision radiation therapy in lung cancer
26-Jun-2024 5:05 PM EDT
Study supports precision radiation therapy in lung cancer
University of Texas MD Anderson Cancer Center

Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with unresectable, locally advanced non-small cell lung cancer (NSCLC).

Released: 26-Jun-2024 12:00 PM EDT
Mesenchymal stem cells-extracellular vesicles alleviate pulmonary fibrosis by regulating immunomodulators
World Journal of Stem Cells

BACKGROUNDPulmonary fibrosis (PF) is a chronic interstitial lung disease characterized by fibroblast proliferation and extracellular matrix formation, causing structural damage and lung failure. Stem cell therapy and mesenchymal stem cells-

Released: 26-Jun-2024 12:00 PM EDT
Outcomes of combined mitochondria and mesenchymal stem cells-derived exosome therapy in rat acute respiratory distress syndrome and sepsis
World Journal of Stem Cells

BACKGROUNDThe treatment of acute respiratory distress syndrome (ARDS) complicated by sepsis syndrome (SS) remains challenging. AIMTo investigate whether combined adipose-derived mesenchymal-stem-cells (ADMSCs)-derived exosome (EXAD) and ex

Not for public release

This news release is embargoed until 25-Jun-2024 11:00 AM EDT Released to reporters: 24-Jun-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Jun-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Summer in the City: Climate Science Reveals the Impacts of Heat
Released: 24-Jun-2024 2:05 PM EDT
Summer in the City: Climate Science Reveals the Impacts of Heat
Department of Energy, Office of Science

The summer sun beats down. People without air conditioning must find refuge in schools and community centers. Outdoor workers struggle to keep cool. Hot nights interrupt people’s sleep, not allowing them to get the rest needed to recover from the warmth of the day. People with cardiovascular and respiratory illnesses have these conditions worsen.

   
Newswise: Cannabis use tied to increased risk of severe COVID-19
19-Jun-2024 3:05 PM EDT
Cannabis use tied to increased risk of severe COVID-19
Washington University in St. Louis

A study by researchers at Washington University School of Medicine in St. Louis shows that people with COVID-19 who used cannabis were more likely to be hospitalized and require intensive care than those who did not use the drug.

Newswise: Swimming microrobots deliver cancer-fighting drugs to metastatic lung tumors in mice
9-Jun-2024 7:30 PM EDT
Swimming microrobots deliver cancer-fighting drugs to metastatic lung tumors in mice
University of California San Diego

UC San Diego engineers have developed microscopic robots, known as microrobots, capable of swimming through the lungs to deliver cancer-fighting medication directly to metastatic tumors.

   
Newswise: New Pathways for Treating Never-Smoker Lung Cancer Revealed
Released: 3-Jun-2024 12:00 AM EDT
New Pathways for Treating Never-Smoker Lung Cancer Revealed
National Research Council of Science and Technology

Korean joint research team have elucidated the overexpression of estrogen signaling pathways in specific Korean never-smoking lung cancer cases using multi-omics analysis and proposed the anti-cancer drug saracatinib as a targeted therapeutic agent.

Newswise: World No Tobacco Day:  Novel Tobacco Products Pose a Danger to Young People
Released: 31-May-2024 11:05 AM EDT
World No Tobacco Day: Novel Tobacco Products Pose a Danger to Young People
American Thoracic Society (ATS)

Despite initiatives around the world to reduce the use of tobacco products amongst young people, smoking is still prevalent in those aged 18 and under. On World No Tobacco Day May 31, the Forum of International Respiratory Societies (FIRS), is encouraging policy makers to take steps to prevent young people from taking up smoking.

Newswise:Video Embedded advancements-in-pediatric-respiratory-medicine-insights-from-leading-researchers
VIDEO
13-May-2024 9:40 AM EDT
VIDEO and TRANSCRIPT: RSV Risk And Undertreated Asthma: Expert Panel Q&A
Newswise

Doctors with the American Thoracic Society will discuss new research about the potential effect of estrogen on hypertension for women in menopause, and the link between hormone replacement and breast cancer risk. How can patients and doctors weigh the risks and benefits and decide whether or not estrogen is right for them?

13-May-2024 9:00 AM EDT
New Tool May Help Prioritize High-Risk Infants for RSV Immunization
American Thoracic Society (ATS)

Pediatric Impact of COVID-19 and Other Respiratory Infections Clinical Prediction Tool for Prioritizing Respiratory Syncytial Virus Prevention Products for High-Risk Infants During Current Limited Availability of Nirsevimab in the United States

Released: 21-May-2024 10:05 AM EDT
Results from Late-Breaking Clinical Trials on COPD and Mycobacterium Avium Complex Lung Disease Announced at ATS 2024
American Thoracic Society (ATS)

This week at the ATS 2024 International Conference, researchers announced results from three clinical trials – the ARISE Study on amikacin liposome inhalation suspension in adults with mycobacterium avium complex disease, Tezepelumab for moderate to very severe COPD (Phase 2A COURSE study), and dupilumab in patients with moderate to severe COPD (Phase 3 NOTUS trial).

Not for public release

This news release is embargoed until 19-May-2024 5:40 PM EDT Released to reporters: 13-May-2024 7:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2024 5:40 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.



close
2.51138